Showing results (121-130 of 332) with videos related to

Sort By:
Pageof 34
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 24, 2011
Fludarabine, antithymocyte globulin, and very low-dose busulfan for reduced-intensity conditioning before allogeneic stem cell transplantation in patients with lymphoid malignanciesFlorent Malard, Xavier Cahu, Aline Clavert, et al.
Leukemia & Lymphoma|June 30, 2010
Reduced-intensity conditioning allogeneic stem cell transplant for relapsed or transformed aggressive B-cell non-Hodgkin lymphomaAline Clavert, Steven Le Gouill, Eolia Brissot, et al.
British Journal of Haematology|March 15, 2023
A 16-month-long experience of COVID-19 in allogeneic haematopoietic stem cell transplantation recipients: An SFGM-TC multicentre cohort studyAliénor Xhaard, Constance Xhaard, Marie-Therese Rubio, et al.
Ejhaem|March 22, 2022
Anti-SARS-CoV-2 vaccines in recipient and/or donor before allotransplantMaxime Jullien, Marianne Coste-Burel, Beatrice Clemenceau, et al.
Haematologica|August 27, 2016
Sequential regimen of clofarabine, cytosine arabinoside and reduced-intensity conditioned transplantation for primary refractory acute myeloid leukemiaMohamad Mohty, Florent Malard, Didier Blaise, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2008
Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TCPatrice Chevallier, Mohamad Mohty, Bruno Lioure, et al.
Blood Advances|December 22, 2020
Optimizing selection of double cord blood units for transplantation of adult patients with malignant diseasesGiancarlo Fatobene, Fernanda Volt, Frederico Moreira, et al.
Bone Marrow Transplantation|May 16, 2019
Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndromeThierry Guillaume, Florent Malard, Leonardo Magro, et al.
American Journal of Hematology|November 21, 2018
Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remissionXavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
European Journal of Haematology|January 11, 2013
Prognostic impact of immune status and hematopoietic recovery before and after fludarabine, IV busulfan, and antithymocyte globulins (FB2 regimen) reduced-intensity conditioning regimen (RIC) allogeneic stem cell transplantation (allo-SCT)Amandine Le Bourgeois, Elsa Lestang, Thierry Guillaume, et al.
Pageof 34